Literature DB >> 2402343

Anticonvulsant effect of N-ethylcarboxamidoadenosine against kainic acid-induced behavioral seizures in the rat prepiriform cortex.

G Zhang1, P H Franklin, T F Murray.   

Abstract

Kainic acid (KA), microinjected unilaterally into the rat prepiriform cortex (PC), produces generalized motor seizures in a dose-dependent manner. The adenosine agonist N-ethylcarboxamidoadenosine (NECA), when co-injected with KA, protects against seizures in a dose-dependent and highly potent manner: ED50 = 25.6 +/- 2.1 pmol/rat. The seizure-suppressing effects of NECA are completely abolished by co-administration of the adenosine receptor antagonist 8-(p-sulfophenyl)theophylline (8-pSPT), suggesting that adenosine receptor activation underlies the efficacy of NECA against KA seizures. Moreover, dilazep, an effective blocker of adenosine uptake, when co-administered with KA, provides significant protection against seizures. Together, these findings suggest that adenosine receptors may play an important role in the regulation of the inhibitory neuronal circuitry of this paleocortical brain area.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2402343     DOI: 10.1016/0304-3940(90)90588-z

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Real-time monitoring of extracellular adenosine using enzyme-linked microelectrode arrays.

Authors:  Jason M Hinzman; Justin L Gibson; Ryan D Tackla; Mark S Costello; Jason J Burmeister; Jorge E Quintero; Greg A Gerhardt; Jed A Hartings
Journal:  Biosens Bioelectron       Date:  2015-07-07       Impact factor: 10.618

2.  Stimulation of 5-HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats.

Authors:  M Gariboldi; P Tutka; R Samanin; A Vezzani
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy.

Authors:  D Young; D M Fong; P A Lawlor; A Wu; A Mouravlev; M McRae; M Glass; M Dragunow; M J During
Journal:  Gene Ther       Date:  2014-09-18       Impact factor: 5.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.